NIH Guide: Weekly Index for December 13, 2024

Funding Opportunities

• Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
  (PAR-24-279)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
  (PAR-24-280)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
  (PAR-24-287)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): February 19, 2025
• Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
  (PAR-24-289)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
  (PAR-25-028)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
  (PAR-25-029)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
  (PAR-25-045)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 16, 2025
• NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
  (PAR-25-141)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
  (PAR-25-154)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
  (PAR-25-155)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
  (PAR-25-156)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
  (PAR-25-157)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): June 19, 2025
• Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
  (PAR-25-196)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
  (PAR-25-197)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
  (PAR-25-224)
  National Institute on Aging
  Application Receipt Date(s): February 21, 2025
• Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
  (PAR-25-230)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
  (PAR-25-247)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
  (PAR-25-277)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
  (PAR-25-296)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Small Business Informatics Tools for the Pangenome (R43 Clinical Trial Not Allowed)
  (PAR-25-308)
  National Human Genome Research Institute
  Application Receipt Date(s): March 03, 2025
• Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed)
  (PAR-25-309)
  National Human Genome Research Institute
  Application Receipt Date(s): March 03, 2025
• Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
  (PAR-25-317)
  National Institute on Minority Health and Health Disparities
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute of Nursing Research
  Office of Research on Women's Health
  Office of Disease Prevention
  Application Receipt Date(s): Multiple dates, see announcement.
• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
  (PAR-25-321)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
  (PAR-25-325)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
  (PAR-25-330)
  National Institute of Allergy and Infectious Diseases
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): Not Applicable
• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
  (PAR-25-346)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
  (RFA-AA-24-012)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): February 19, 2025
• Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)
  (RFA-AG-25-001)
  National Institute on Aging
  Application Receipt Date(s): February 14, 2025
• Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed)
  (RFA-AG-25-015)
  National Institute on Aging
  Application Receipt Date(s): February 14, 2025
• Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed)
  (RFA-AI-24-080)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 02, 2025
• NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
  (RFA-DK-26-001)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
  (RFA-EY-25-001)
  National Eye Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
  (RFA-MD-24-011)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): January 25, 2025
• Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
  (RFA-NR-25-003)
  National Institute of Nursing Research
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Environmental Health Sciences
  Office of Disease Prevention
  Application Receipt Date(s): February 28, 2025
• Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)
  (RFA-RM-24-010)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): February 28, 2025